$RGBP The NR2F6 nuclear receptor has been identif
Post# of 6705
(Total Views: 146)
Posted On: 03/23/2017 9:14:30 AM
$RGBP The NR2F6 nuclear receptor has been identified as a potentially significant immune cell inhibitor (an immune checkpoint) and cancer stem cell differentiator. The NR2F6 program at Regen aims to identify antagonists of NR2F6, in an effort to unleash the cancer-killing potential of a patient's own immune system, as well as identifying agonists, which should suppress the immune system in diseases where the immune system is over-activated, such as rheumatoid arthritis and other autoimmune diseases.
https://finance.yahoo.com/news/regen-biopharm...00232.html
https://finance.yahoo.com/news/regen-biopharm...00232.html
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!